These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24435068)

  • 21. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
    Furuse M; Kawabata S; Kuroiwa T; Miyatake S
    J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
    Narita Y
    Jpn J Clin Oncol; 2013 Jun; 43(6):587-95. PubMed ID: 23585688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
    Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
    Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
    Liu AK; Macy ME; Foreman NK
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation schedules in relation to obliteration and complications in hypofractionated conformal stereotactic radiotherapy of arteriovenous malformations.
    Lindvall P; Bergström P; Blomquist M; Bergenheim AT
    Stereotact Funct Neurosurg; 2010; 88(1):24-8. PubMed ID: 19940546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Parenchymal changes after radiosurgery of cerebral arteriovenous malformations. Clinical and MRI data].
    Nataf F; Ghossoub M; Missir O; Beuvon F; Varlet P; Merienne L; Schlienger M; Roux FX
    Neurochirurgie; 2001 May; 47(2-3 Pt 2):355-68. PubMed ID: 11404717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
    Gupta A; Muecke JS
    Retina; 2008; 28(7):964-8. PubMed ID: 18698298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
    Mason JO; Albert MA; Persaud TO; Vail RS
    Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment predictors of adverse radiation effects after radiosurgery for arteriovenous malformation.
    Hayhurst C; Monsalves E; van Prooijen M; Cusimano M; Tsao M; Menard C; Kulkarni AV; Schwartz M; Zadeh G
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):803-8. PubMed ID: 21345621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bevacizumab reverses cerebral radiation necrosis.
    Wong ET; Huberman M; Lu XQ; Mahadevan A
    J Clin Oncol; 2008 Dec; 26(34):5649-50. PubMed ID: 18981459
    [No Abstract]   [Full Text] [Related]  

  • 32. A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis.
    Zhuang H; Yuan X; Zheng Y; Li X; Chang JY; Wang J; Wang X; Yuan Z; Wang P
    Sci Rep; 2016 Apr; 6():24364. PubMed ID: 27067388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A 32-year-old man who developed a posterior fossa mass 12 years after the radiation therapy for cerebellar arteriovenous malformation].
    Koshimura I; Takeda N; Ohtomo T; Shimada J; Sugano K; Mori H; Mizuno Y; Sato K
    No To Shinkei; 1996 Jan; 48(1):81-9. PubMed ID: 8679325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic radiosurgery for arteriovenous malformations, part 2: management of pediatric patients.
    Kano H; Kondziolka D; Flickinger JC; Yang HC; Flannery TJ; Awan NR; Niranjan A; Novotny J; Lunsford LD
    J Neurosurg Pediatr; 2012 Jan; 9(1):1-10. PubMed ID: 22208313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exacerbation of cerebral radiation necrosis by bevacizumab.
    Jeyaretna DS; Curry WT; Batchelor TT; Stemmer-Rachamimov A; Plotkin SR
    J Clin Oncol; 2011 Mar; 29(7):e159-62. PubMed ID: 21149667
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperbaric oxygen in the treatment of a radiosurgical complication: technical case report.
    Lynn M; Friedman WA
    Neurosurgery; 2007 Mar; 60(3):E579; discussion E579. PubMed ID: 17327770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin).
    Finger PT
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):974-7. PubMed ID: 18313522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CT and MRI aspects of 28 patients with cerebral radiation necrosis irradiated for ORL tumors: correlation with the radiation technique].
    Gaucher S; Viala J; Lusinchi A; Vanel D; Sigal R
    J Radiol; 2002 Nov; 83(11):1749-57. PubMed ID: 12469012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas.
    Arratibel-Echarren I; Albright K; Dalmau J; Rosenfeld MR
    Neurologia; 2011 Mar; 26(2):74-80. PubMed ID: 21163238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of Gamma Knife surgery for arteriovenous malformations: 10- to 15-year follow up in patients treated with lower doses.
    Inoue HK
    J Neurosurg; 2006 Dec; 105 Suppl():64-8. PubMed ID: 18503332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.